STOCK TITAN

Orthopedia - KIDS STOCK NEWS

Welcome to our dedicated page for Orthopedia news (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on Orthopedia stock.

Overview

Orthopedia (KIDS) is a specialized medical device company dedicated exclusively to the field of pediatric orthopedics. Operating at the intersection of advanced medical technology and clinical expertise, the company designs, develops, and commercializes anatomically appropriate implants and surgical instruments. These innovative solutions are crafted to meet the distinct needs of pediatric patients, addressing conditions from long bone deformity correction and trauma management to spinal procedures and sports medicine. Keywords such as pediatric orthopedics, surgical implants, and clinical education reinforce the company’s technical focus from the very first introduction.

Core Business and Product Offering

At the heart of Orthopedia's operations lies a commitment to empowering pediatric orthopedic surgeons. The company’s product portfolio encompasses a range of state-of-the-art implants and instruments – each meticulously engineered to provide optimal treatment outcomes. Their offerings include specialized devices that aid in the correction of limb deformities, stabilization of fractures, and support for reconstructions, all designed with the care and precision that pediatric cases demand.

  • Dedicated Research and Development: Orthopedia invests in continuous innovation, leveraging cutting-edge technology to refine implant design and improve surgical outcomes.
  • Clinical and Educational Support: Beyond product development, the company emphasizes comprehensive clinical education and support programs that help surgeons stay updated on the latest procedures and applications.
  • Comprehensive Product Range: From long bone deformity correction to trauma, spine care, and sports medicine, the company offers an integrated suite of solutions tailored for pediatric needs.

Market Position and Industry Significance

Orthopedia has positioned itself as a trusted name within the pediatric orthopedic market. With an unwavering focus on quality and innovation, the company has developed an expertise that ensures its products meet rigorous safety and efficacy standards. Its dedicated approach sets it apart from competitors who cover broader orthopedic applications, as Orthopedia champions solutions specifically designed for children. This clear specialization has cemented its role as a key industry resource for surgeons looking for products that reliably address pediatric orthopaedic conditions.

Operational Excellence and Expertise

The company’s operational framework is built upon a solid foundation of expert knowledge and technical prowess. By integrating engineering innovation with clinical insight, Orthopedia ensures that every implant and instrument is both practical in a surgical environment and tailored for the unique demands of pediatric physiology. The emphasis on quality, reliability, and educational support further demonstrates a commitment to elevating standard practices within the field. This multifaceted approach underlines the company’s role as not only a supplier of medical devices, but also as a partner in advancing pediatric orthopedic care globally.

Customer and Stakeholder Focus

Orthopedia’s offerings are crafted with the end-user in mind, primarily targeting healthcare institutions and pediatric orthopedic surgeons. The company’s comprehensive support system includes detailed training and ongoing clinical education, ensuring that surgeons are capable of utilizing these advanced tools to their fullest potential. Through its balanced approach to innovation and education, Orthopedia helps customers achieve better surgical outcomes and improved quality of life for pediatric patients.

Conclusion

In summary, Orthopedia (KIDS) exemplifies an unwavering focus on the niche field of pediatric orthopedics. The company combines advanced product engineering, dedicated clinical support, and a targeted market strategy to address the specialized needs of pediatric surgical care. By maintaining a consistent emphasis on quality and clinical expertise, Orthopedia continues to serve as a central resource for pediatric orthopedic solutions in the healthcare industry.

Rhea-AI Summary
OrthoPediatrics Corp. (KIDS) issues 2024 financial guidance, reporting a 21% growth in net revenue for the fourth quarter of 2023 compared to the same period in 2022. The company expects to reach a net revenue of $148.7 million for the full year of 2023, with domestic net revenue growing by 20% and international net revenue growing by 26%. OrthoPediatrics also acquired Boston O&P, with a projected $197 million to $200 million revenue for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
none
-
Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) has acquired Boston Orthotics & Prosthetics, a leader in pediatric orthotic management for over 50 years, and closed an $80 million debt financing with MidCap Financial. The acquisition expands OrthoPediatrics' Specialty Bracing division and provides leading technology and pediatric care through dedicated clinics. The transaction details include an upfront cash payment of $22 million, and OrthoPediatrics' cash and restricted cash balance post-closing is approximately $60 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
-
Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) announced the launch of its new division, OrthoPediatrics Specialty Bracing division (OPSB), focusing on non-surgical intervention for pediatric orthopedics. The division aims to expand the Company’s Total Addressable Market by approximately $600 million, following the acquisition of MD Orthopaedics, Inc. (MDO) and Rhino Pediatric Orthopedic Designs, Inc. The Company also introduced the DF2® Brace and partnered with Ora Medical to distribute The Levity, a gait-trainer device for children with walking difficulties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
none
Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) increases its support of IPOS as an Emerald-Level sponsor, showcasing its expanding product portfolio at the event. Over 500 pediatric orthopedic surgeons are registered to attend the meeting from December 5-9, in Orlando, Florida. The company aims to connect with its surgeon customers and continue to partner with them in education, emphasizing its commitment to advancing the field of pediatric orthopedics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
conferences
-
Rhea-AI Summary
OrthoPediatrics Corp. (NASDAQ: KIDS) announces participation in fireside chats at Stifel 2023 Healthcare Conference and Piper Sandler 35th Annual Healthcare Conference. The company's President & CEO and COO/CFO will discuss at the events, with audio webcasts and replays available online at the OrthoPediatrics investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences
-
Rhea-AI Summary
OrthoPediatrics Corp. reported record-setting quarterly revenue of $40.0 million, a 14% increase compared to the same period last year. The company helped over 22,000 children in Q3 2023, bringing the total to over 692,000 since inception. Adjusted EBITDA reached $3.6 million, up from $1.9 million in Q3 2022. OrthoPediatrics launched new products, including the Pediatric Nailing Platform TIBIA system and the DF2 Brace. The company reiterated its full-year 2023 revenue guidance of $148.0 million to $151.0 million, representing 21% to 23% growth compared to the prior year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.19%
Tags
Rhea-AI Summary
OrthoPediatrics Corp. has entered into an exclusive Distribution Agreement with Ora Medical to sell The Levity, a gait trainer for children with walking difficulties. The device features a personalized treatment, adjustable features, and a foldable design. The partnership aims to improve the mobility of children globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
none
-
Rhea-AI Summary
OrthoPediatrics Corp. has announced the limited release of the Mitchell Ponseti Plus Bar (MP+) as part of their Specialty Bracing portfolio for kids with clubfoot. The new MP+ Bar features several innovations and enhancements compared to their traditional Bar. The company is also developing the MP Lite boots & bar system for markets outside the United States. OrthoPediatrics plans to continue launching new innovative products to address the large unmet needs in the pediatric orthopedic market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
none
-
Rhea-AI Summary
OrthoPediatrics Corp. announces the release of the Pediatric Nailing Platform TIBIA system and successful completion of the first cases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
none
Rhea-AI Summary
OrthoPediatrics Corp. to release third quarter 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.67%
Tags
conferences earnings

FAQ

What is the current stock price of Orthopedia (KIDS)?

The current stock price of Orthopedia (KIDS) is $21 as of April 17, 2025.

What is the market cap of Orthopedia (KIDS)?

The market cap of Orthopedia (KIDS) is approximately 521.0M.

What is Orthopedia's core business?

Orthopedia focuses exclusively on pediatric orthopedics, designing and developing specialized implants and surgical instruments tailored for children.

How does Orthopedia differentiate itself from other orthopedic companies?

By concentrating solely on pediatric applications, Orthopedia provides anatomically precise implants and comprehensive clinical education, addressing the unique challenges of pediatric orthopedic care.

What types of products does Orthopedia offer?

The company offers a broad range of products including implants for long bone deformity correction, trauma management, spine care, and sports medicine, along with specialized surgical instruments.

Who are the primary customers of Orthopedia?

Orthopedia primarily serves pediatric orthopedic surgeons and healthcare institutions, providing them with both the necessary surgical devices and clinical educational support.

How does Orthopedia support clinical education?

The company offers ongoing training and educational programs designed to keep surgeons informed about the latest techniques and proper use of their specialized implants and instruments.

What is the significance of technology and innovation for Orthopedia?

Orthopedia leverages cutting-edge technology to continually improve its products, ensuring that its implants and instruments meet the high safety and efficacy standards required in pediatric care.

How does Orthopedia ensure product quality?

The company adheres to rigorous research and development protocols, integrating clinical insights with advanced engineering practices to maintain the highest quality standards in its products.
Orthopedia

Nasdaq:KIDS

KIDS Rankings

KIDS Stock Data

520.96M
16.71M
32.42%
71.18%
4.02%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
WARSAW